Gaxos.ai gets Nasdaq minimum bid price deficiency notice; has until March 29, 2027 to cure

GAXOS.AI INC.

Nasdaq notified Gaxos.ai on Sept 28, 2026 that it fails Listing Rule 5550(a)(2) after its closing bid stayed below $1.00 from Aug 14 to Sept 25, 2026.
Company has 180 days, until March 29, 2027, to regain compliance by holding a closing bid of at least $1.00 for 10 consecutive business days.
If it fails to cure, Nasdaq may grant a second 180-day period; otherwise Nasdaq would issue a delisting determination, which Gaxos.ai could appeal to a Hearings Panel.
Gaxos.ai said it may implement a reverse stock split to regain compliance; shares continue trading on the Nasdaq Capital Market under 'GXAI' in the meantime.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.